Business
2022 Annual Report and 2023 AGM Notice
2022 Annual Report and 2023 AGM Notice.
About this update from Shield Therapeutics Plc
[{"type":"text","content":"\n\nShield Therapeutics plc\n(\"Shield\" or the \"Company\" or the \"Group\")\n \n2022 Annual Report and 2023 AGM Notice\n \nLondon, UK, 19 May 2023: Shield Therapeutics plc (LSE: STX), a commercial stage pharmaceutical company focused on the commercialisation of its innovative oral iron therapy for iron deficiency, Accrufer®/Feraccru® (ferric maltol), announces that the following documents have now been sent to shareholders:\n \n· Annual Report and Accounts for the year ended 31 December 2022\n· Notice of Annual General Meeting (\"AGM\") 2023\nIn accordance with AIM Rule 26, these documents are also available to view on the Company's website: Results, Reports & Presentations | Shield Therapeutics plc.\n \nThis year the Company's AGM will be held at 2.00pm (BST) on 28 June 2023 at the offices of Shield Therapeutics plc, Northern Design Centre, Baltic Business Quarter, Gateshead Quays, England NE8 3DF. \n \nIf you wish to attend the AGM in your capacity as a shareholder, please bring proof of shareholding or if shares are held through a nominee account, a letter of representation, to facilitate your entry to the Meeting.\n \nThe Company will provide a facility for shareholders to join the AGM online and telephonically and there will be an opportunity for shareholders to ask questions. In order to facilitate the process, the Board would request that shareholders register for the meeting and submit questions in advance, before 2.00pm (BST) on 26 June 2023.\n\nTo register for dial-in details and to submit any questions please contact Walbrook PR via email at [email protected] or call +44 (0)20 7933 8780.\n \n \nFor further information please contact:\n \n\n\n\n\nShield Therapeutics plc\n\n\nwww.shieldtherapeutics.com\n\n\n\n\nGreg Madison, CEO\n\n\n+44 (0) 191 511 8500\n\n\n\n\nHans-Peter Rudolf, CFO\n\n\n\n\n\n\n\n \nNominated Adviser and Joint Broker\n\n\n\n\n\n\n\nPeel Hunt LLP\n\n\n\n\n\n\n\nJames Steel/Oliver Duckworth\n\n\n+44 (0)20 7418 8900\n\n\n\n\n \nJoint Broker\nfinnCap Ltd \nGeoff Nash/George Dollemore/Alice Lane/Nigel Birks/Harriet Ward ...